News

30/12/2019

The 2019 wins for the Access to Medicines movement

2019 was an exciting year for those who work in the field of pharmaceutical policy. The topic of access to medicines is climbing higher on the political agenda. Not just in the Netherlands. Read more

News

5/12/2019

How healthy is a ‘healthy’ economy? A closer look into SDG goals

To realise the Sustainable Development Goals (SDGs) everywhere, governments should abandon Gross Domestic Product (GDP) growth as a policy objective and place more emphasis on SDG17 on global co-operation. Read more

News

2/11/2019

Abuse of orphan designation leads to exorbitant drug price

Pharmaceutical company Lupin Europe is aiming to bring an existing medicine for a rare muscle disease on the market under a new name and at a much higher price. Read more

News

24/10/2019

Seeking a medicine system that is socially sustainable balanced

With prices of medicines skyrocketing under the current system of medicine development, the shortcomings of this R&D model are increasingly becoming clear. Read more

News

11/10/2019

Best public value for public money?

Wemos conducted a case study on the application of Dutch Official Development Assistance (ODA) policy instruments for business strengthening in the healthcare context. Read more

News

9/10/2019

Discussing public private partnerships at the world of health care

In today’s global health landscape, Public Private Partnerships, or PPPs, are continuosly being formed to tackle some of the most pressing challenges of our era, that indeed call for a multi-sectoral approach and sustained collaboration between all actors. Read more

News

4/10/2019

Our input for the youth, education and employment strategy

The Dutch Ministry of Foreign Affairs (MoFa) is developing a strategy to invest in better future prospects for young people, with a focus on education and work. Read more

News

27/9/2019

Ending HIV by realising Universal Health Coverage

In our advocacy for more and better financing for health, we find it important that the call for adequately funding Universal Health Coverage (UHC) takes on board the lessons learned on funding for HIV. Read more

News

26/9/2019

Pharmalobby in Brussels: Wemos in Follow the money

A well-balanced debate on fair drug prices in Brussels is still being obstructed on all sides by the continuous pharma lobby, reports EU correspondent Lise Witteman from Follow The Money. Read more